Nanjing Vazyme Biotech Co., Ltd (SHA:688105)
China
· Delayed Price · Currency is CNY 20.01
-0.26 (-1.28%)
Mar 10, 2026, 9:25 AM CST
Nanjing Vazyme Biotech Market Cap
Nanjing Vazyme Biotech has a market cap or net worth of 7.96 billion as of March 9, 2026. Its market cap has decreased by -6.34% in one year.
Market Cap
7.96B
Enterprise Value
6.10B
Revenue
1.38B
Ranking
n/a
PE Ratio
n/a
Stock Price
20.01
Market Cap Chart
Since November 15, 2021, Nanjing Vazyme Biotech's market cap has decreased from 34.14B to 7.96B, a decrease of -76.69%. That is a compound annual growth rate of -28.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 7.96B | -0.05% |
| Dec 31, 2025 | 7.96B | -9.63% |
| Dec 31, 2024 | 8.81B | -31.21% |
| Dec 29, 2023 | 12.81B | -39.74% |
| Dec 30, 2022 | 21.26B | -49.87% |
| Dec 31, 2021 | 42.40B | 24.19% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chengdu Kanghua Biological Products | 8.08B |
| Anhui Huaheng Biotechnology | 7.99B |
| Suzhou Fengbei Biotech Stock | 7.92B |
| Jiangxi Fushine Pharmaceutical | 8.25B |
| Zhejiang Ausun Pharmaceutical | 7.83B |
| Youcare Pharmaceutical Group | 8.43B |
| Acrobiosystems | 7.53B |
| Daan Gene | 8.63B |